Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia

American Journal of Psychiatry

Volumn 149, Issue 4, 1992, Pages 506-510

  Barbee, James G ^a   Mancuso, Donna M ^a   Freed, Charles R ^a   Todorov, Alexandre A ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; HALOPERIDOL; PLACEBO;

ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EMERGENCY TREATMENT; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; RANDOMIZATION; RELAPSE; SCHIZOPHRENIA;

ADULT; ALPRAZOLAM; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EMERGENCIES; EMERGENCY SERVICES, PSYCHIATRIC; FEMALE; HALOPERIDOL; HUMAN; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUPPORT, NON-U.S. GOV'T;

EID: 0026572732     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.149.4.506     Document Type: Article

References (29)

1. Cohen BM, Lipinski JF Jr: Treatment of acute psychosis with non-neuroleptic agents. Psychosomatics 1986; 27(Jan suppl):7-16
2. Cohen S, Khan A, Johnson S: Pharmacological management of manic psychosis in an unlocked setting. J Clin Psychopharmacol 1987; 7:261-264
3. Busch FN, Miller FT, Weiden PJ: A comparison of two adjunctive treatment strategies in acute mania. J Clin Psychiatry 1989; 50:453-455
4. Cohen S, Khan A: Adjunctive benzodiazepines in acute schizophrenia. Neuropsychobiology 1987; 18:9-12
5. Garza-Treviño ES, Hollister LE, Overall JE, Alexander WF: Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation. Am J Psychiatry 1989; 146:1598-1601
6. Mendoza R, Djenderedjian AH, Adams J, Ananth J: Midazolam in acute psychotic patients with hyperarousal. J Clin Psychiatry 1987; 48:291-292
7. Salzman C, Green AI, Rodriguez-Villa F, Jaskiw GI: Benzodiazepines combined with neuroleptics for management of severe disruptive behavior. Psychosomatics 1986; 27(Jan suppl):17-22
8. Arana GW, Ornsteen ML, Kanter F, Friedman HL, Greenblatt DJ, Shader RI: The use of benzodiazepines for psychotic disorders: a literature review and preliminary clinical findings. Psy- chopharmacol Bull 1986; 22:77-87
9. Dubin WR: Rapid tranquilization: antipsychotics or benzodiazepines? J Clin Psychiatry 1988; 48(Dec suppl):5-12
10. Easton MS, Janicak PG: The use of benzodiazepines in psychotic disorders: a review of the literature. Psychiatr Annals 1990; 20:535-544
11. Wolkowitz OM, Breier A, Doran A, Kelsoe J, Lucas P, Paul SM, Pickar D: Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients: preliminary results. Arch Gen Psychiatry 1988; 45:664-671
12. Douyon R, Angrist B, Peselow E, Cooper T, Rotrosen J: Neuroleptic augmentation with alprazolam: clinical effects and pharmacokinetic correlates. Am J Psychiatry 1989; 146:231-234
13. Csernansky JG, Riney SJ, Lombrozo L, Overall JE, Hollister LE: Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms. Arch Gen Psychiatry 1988; 45:655-659
14. Andreason NC: The Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa, 1983
15. Andreason NC: The Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1983
16. Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
17. Snedecor GW, Cochran WG: Statistical Methods. Ames, University of Iowa Press, 1982, pp 243-244
18. Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand (Suppl) 1970; 212:9-11
19. Detre TP, Jarecki HG: Modern Psychiatric Treatment. Philadelphia, JB Lippincott, 1971, p 93
20. Greenblatt DJ, Divoll M, Shader RI: Automated gas chromatographic determination of plasma alprazolam concentrations. J Clin Psychopharmacol 1983; 3:366-368
21. Burstein ES, Friedman H, Greenblatt DJ: Simplified measurement of haloperidol by gas chromatography with nitrogen-phosphorus detection. J Chromatogr 1987; 423:380-382
22. Looney SW, Stanley WB: Exploratory repeated measures analysis for two or more groups. Am Statistician 1989; 43:220-225
23. Marsden CD, Tarsy D, Baldessarini RJ: Spontaneous and drug-induced movement disorders in psychotic patients, in Psychiatric Aspects of Neurologic Disease. Edited by Benson DF, Blumer D. New York, Grune & Stratton, 1975
24. Ciraulo DA, Shader RI, Greenblatt DJ, Creelman W: Drug Interactions in Psychiatry. Baltimore, Williams & Wilkins, 1989
25. Grasela TH, Antal EJ, Ereshefsky L, Wells BG, Evans RL, Smith RB: An evaluation of population pharmacokinetics in therapeutic trials, part II: detection of a drug-drug interaction. Clin Pharmacol Ther 1987; 42:433-441
26. Bertilsson L, Aberg-Wistedt A, Liden A, Otani K, Spina E: Alprazolam does not inhibit the metabolism of nortriptyline in depressed patients or inhibit the metabolism of desipramine in human liver microsomes. Ther Drug Monit 1988; 10:231-233
27. Nestoros JN: Benzodiazepines in schizophrenia: a need for reassessment. Int Pharmacopsychiatry 1980; 15:171-179
28. van Kammen DP: γ-Aminobutyric acid (Gaba) and the dopamine hypothesis of schizophrenia. Am J Psychiatry 1977; 134:138-143
29. Ciraulo DA, Antal EJ, Smith RB, Olson DR, Goldberg DA, Rand EH, Raskin RB, Phillips JP, Shader RI, Greenblatt DJ: The relationship of alprazolam dose to steady-state plasma concentrations. J Clin Psychopharmacol 1990; 10:27-32